{"product_id":"envistaco-five-forces-analysis","title":"Envista Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eEnvista navigates moderate buyer power and supplier concentration, with steady barriers to entry but rising competitive intensity from tech-enabled dental players and potential substitutes in at-home care.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Envista’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Medical Grade Material Sourcing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEnvista depends on a small set of certified vendors for high-purity titanium and specialty polymers used in implants and orthodontics; in 2024 about 65% of surgical implant input spent was on these materials, raising supplier importance. \u003c\/p\u003e\n\u003cp\u003eThese suppliers wield power because materials must meet strict FDA, EU MDR and Japan PMDA standards that take 12–24 months to qualify, so disruptions can force Envista to absorb price hikes to keep production running. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependency on Semiconductor and Electronic Components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe shift to digital dentistry and advanced imaging has raised Envista’s dependence on global semiconductor and electronic suppliers; semiconductors accounted for an estimated 18–22% of component spend in 2024 for dental imaging lines, per industry sourcing data. Supplier shortages and 2021–24 chip price volatility (up to +40% peak) can compress equipment margins directly, since Envista lacks bargaining clout vs. large fabs and Tier-1 electronics firms. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Global Freight Reliability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialized logistics for dental consumables and heavy imaging gear needs temp-controlled and high-security carriers; in 2025, global air freight rates rose ~18% YoY and bunker fuel jumped ~25%, letting carriers push up fees and raising Envista’s COGS pressure.\u003c\/p\u003e\n\u003cp\u003eTimely delivery ties to clinic schedules, so Envista faces high supplier power: switching providers risks 5–10 day delays and potential revenue loss; logistics make up an estimated 4–6% of Envista’s operating costs, limiting bargaining room.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property Licensing for Digital Software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEnvista relies on third-party algorithms and AI diagnostic tools under ongoing licenses; in 2025 roughly 18–22% of R\u0026amp;D-related software costs stem from vendor fees, raising supplier leverage.\u003c\/p\u003e\n\u003cp\u003eProprietary code and integration costs—estimated at $0.5–1.2M per major device line redeployment—make switching costly, so Envista typically absorbs price increases to maintain market parity.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18–22% of software R\u0026amp;D costs from vendor licenses\u003c\/li\u003e\n\u003cli\u003e$0.5–1.2M average re-integration cost per device line\u003c\/li\u003e\n\u003cli\u003eSupplier pricing power due to proprietary IP\u003c\/li\u003e\n\u003cli\u003eEnvista absorbs updates to stay competitive\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Labor for Precision Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialized labor and outsourced high-tech manufacturing for precision dental instruments command premium rates due to scarce medical-grade engineering talent in late 2025; global median wage for precision manufacturing engineers rose ~9% YoY to about $98,000 in 2025, pressuring supplier leverage.\u003c\/p\u003e\n\u003cp\u003eEnvista faces cost-control limits as competing OEMs and contract manufacturers bid up skilled labor and long-term contracts, with select suppliers holding \u0026gt;20% margin or capacity constraints in key regions.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSkilled labor scarcity: +9% median wage (2025)\u003c\/li\u003e\n\u003cli\u003eSupplier margins: \u0026gt;20% in niche contract fabs\u003c\/li\u003e\n\u003cli\u003eCapacity bottlenecks in US\/EU\/India\u003c\/li\u003e\n\u003cli\u003eEnvista exposed to wage and contract inflation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier concentration, rising logistics \u0026amp; wages squeeze Envista margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnvista faces high supplier power: 65% of implant spend tied to certified titanium\/polymers, 18–22% of imaging component spend on semiconductors, and 18–22% of R\u0026amp;D software costs from licensed AI, making switches slow (12–24 months) and costly ($0.5–1.2M per device line); logistics and labor inflation (air freight +18% YoY 2025; median precision engineer wage +9% to $98,000) compress margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eImplant material spend (2024)\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging component spend (semiconductors, 2024)\u003c\/td\u003e\n\u003ctd\u003e18–22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D software vendor share (2025)\u003c\/td\u003e\n\u003ctd\u003e18–22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRe-integration cost per device line\u003c\/td\u003e\n\u003ctd\u003e$0.5–1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChip price volatility (2021–24 peak)\u003c\/td\u003e\n\u003ctd\u003e+40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAir freight YoY (2025)\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision engineer median wage (2025)\u003c\/td\u003e\n\u003ctd\u003e$98,000 (+9% YoY)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis of Envista that uncovers key competitive drivers, supplier and buyer power, substitution risks, and entry barriers, highlighting disruptive threats and strategic levers to protect market share and profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise Porter's Five Forces summary tailored for Envista—quickly spot competitive pressures and prioritize strategic moves.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Dental Service Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe rapid rise of Dental Service Organizations (DSOs) — top 20 groups now operating \u0026gt;25% of US dental practices and companies like Smile Brands managing 1,000+ offices — shifts bargaining power to corporate buyers who push for volume discounts. These DSOs demand standardized pricing and integrated digital workflows across networks, so Envista must serve high-volume accounts and may accept slimmer gross margins to retain share; in 2024 Envista reported ~36% of sales to dental chains, highlighting exposure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProcurement Strategies of Large Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa significant share of envista product revenue per the company filings through major dental distributors who act as intermediaries to clinics giving these gatekeepers leverage favor brands that meet their margin or promotional targets. can re-rank supplier visibility via shelf placement bundled promotions rebate programs so must fund incentives accept lower margins secure access. maintaining exclusive agreements co-op marketing and volume discounts keeps implants consumables visible end-users helps protect its market in restorative products.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Sensitivity in General Dentistry Consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIndividual dentists show high price sensitivity for consumables—resins, bonding agents, handpieces—driven by thin margins; a 2024 ADA survey found 62% of private practices prioritize price for routine supplies.\u003c\/p\u003e\n\u003cp\u003eTransparent online marketplaces grew 28% YoY in 2023, letting clinicians compare and switch to lower-cost brands for commodity items.\u003c\/p\u003e\n\u003cp\u003eEnvista must prove clinical value and differentiate premium brands; otherwise a 10–15% churn in non-specialized SKUs is likely, per industry reseller reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Autonomy versus Corporate Purchasing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIndividual dentists value clinical autonomy, but by 2024 about 60% of US dental practices were owned or affiliated with DSOs (dental support organizations), shifting purchasing to centralized procurement and cutting reps' influence.\u003c\/p\u003e\n\u003cp\u003eEnvista must sell to clinicians and to corporate procurement—targeting clinical outcomes for end-users and ROI\/cost metrics for CFOs—to win multi-year DSO contracts worth millions per account.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~60% US DSO affiliation (2024)\u003c\/li\u003e\n\u003cli\u003eCentralized purchasing reduces rep-driven sales\u003c\/li\u003e\n\u003cli\u003eDual-target strategy: clinical benefits + financial ROI\u003c\/li\u003e\n\u003cli\u003eFocus on multi-year contracts, account-level value\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccess to Comparative Performance Data\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy end-2025, digital platforms and peer-review networks boosted access to objective dental-product performance data, with PubMed-indexed implant studies rising ~12% YoY and real-world evidence registries reporting 20–30% larger sample sizes versus 2020.\u003c\/p\u003e\n\u003cp\u003eThat transparency lets clinicians demand better outcomes or lower prices based on comparative trials and registry data, pressuring margins.\u003c\/p\u003e\n\u003cp\u003eEnvista must increase clinical-validation spend—estimated +15–25% capex\/SG\u0026amp;A—to defend pricing where information symmetry is high.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePubMed implant studies +12% YoY\u003c\/li\u003e\n\u003cli\u003eRWE registries +20–30% sample growth\u003c\/li\u003e\n\u003cli\u003eRecommended Envista clinical spend +15–25%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDSO buying, marketplaces \u0026amp; transparency force Envista to hike clinical spend to defend margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDSOs and major distributors concentrated purchasing power, with ~60% US practices DSO-affiliated (2024) and Envista reporting ~36% sales to chains, push prices down and demand volume\/standardization; digital marketplaces (+28% YoY 2023) and rising clinical transparency (PubMed implant studies +12% YoY) force Envista to boost clinical spend (~+15–25%) to defend margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDSO affiliation (2024)\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnvista sales to chains (2024)\u003c\/td\u003e\n\u003ctd\u003e~36%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital marketplace growth (2023)\u003c\/td\u003e\n\u003ctd\u003e+28% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePubMed implant studies growth\u003c\/td\u003e\n\u003ctd\u003e+12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecommended clinical spend\u003c\/td\u003e\n\u003ctd\u003e+15–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eEnvista Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Envista Porter's Five Forces analysis you'll receive immediately after purchase—fully formatted, professionally written, and ready for use with no placeholders or mockups.\u003c\/p\u003e\n\u003cp\u003eThe document displayed here is the complete deliverable; once you buy you'll get instant access to this same file for download and application to your strategic or investment work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747468849529,"sku":"envistaco-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/envistaco-five-forces-analysis.png?v=1772198901","url":"https:\/\/growthsharematrix.com\/products\/envistaco-five-forces-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}